Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse

NCT05533164 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: Rituximab
DRUG: Placebo

Sponsor

Sint Maartenskliniek

Collaborators

[object Object]
[object Object]